Print Page     Close Window     

SEC Filings

SC 13G
ALTIUM CAPITAL MANAGEMENT LP filed this Form SC 13G on 02/08/2019
Entire Document


CUSIP No . 81577F109   Page 6 of 7


Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
  (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
  (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
  (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
  (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
  (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g) A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
  (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
  (j) Group, in accordance with §240.13d-1(b)(1)(ii)(J).
Item 4. Ownership.
  Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

The information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.  The percentage set forth in Row 11 of the cover page for each Reporting Person is based on 6,221,822 shares of Common Stock issued and outstanding as of January 24, 2019, as represented in the Company’s Current Report on Form 8-K Form filed with the Securities and Exchange Commission on January 24, 2019, and assumes the exercise of the Company's reported warrants (the "Reported Warrants") and, subject to the Blockers (as defined below).


Pursuant to the terms of the Reported Warrants, the Reporting Persons cannot exercise the Reported Warrants to the extent the Reporting Persons would beneficially own, after any such exercise, more than 9.99% of the outstanding shares of Common Stock (the "Blocker"), and the percentage set forth in Row 11 of the cover page for each Reporting Person gives effect to the Blocker.





© Apricus Biosciences, Inc.